High Vista Strategies LLC Curis Inc Transaction History

High Vista Strategies LLC

  • $249 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.45 - $8.09 $767,095 - $1.39 Million
-172,381 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$6.94 - $8.85 $794,442 - $1.01 Million
114,473 Added 197.68%
172,381 $1.35 Million
Q2 2021

Aug 16, 2021
SELL
$7.45 - $16.27 $117,970 - $257,635
-15,835 Reduced 21.47%
57,908 $467,000
Q1 2021

May 17, 2021
BUY
$8.78 - $12.8 $647,463 - $943,910
73,743 New
73,743 $835,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email